BiondVax expands manufacturing capabilities for universal flu vaccine
BiondVax moved into a new facility with an increased capacity of 40 million doses per year ahead of potential approval for its universal flu vaccine.
Archives for September 4, 2018
MHRA and EMA divorce process continues ahead of Brexit deadline
It has been revealed that the EMA is awarding significantly fewer contracts to evaluate the application of new drugs to the MHRA, as the Brexit deadline nears.
Australian government awards funding to Indee Labs for microfluidic chip development
NSW Medical Device Fund awarded Indee Labs funding for the company’s preclinical trial with their microfluidic chip alongside University of Sydney.